Mehra Golshan

9.6k citations
176 papers · 6.3k indexed · 2 hit papers · h-index 41

Mehra Golshan

170 papers receiving 6.2k citations

Hit Papers

Addition of the PARP inhibitor veliparib plus carboplatin...5162014202620182022200400600

Peers

Mehra Golshan
Comparison fields: 5 of 137
  • Cancer Research 3.9k
  • Oncology 3.2k
  • Pathology and Forensic Medicine 1.9k
  • Dermatology 380
  • Surgery 1.5k
Replace Byeong‐Woo Park with:
Byeong‐Woo Park South Korea
Tari A. King United States
Isabelle Bedrosian United States
Michelle C. Specht United States
Constance Cirrincione United States
Nora Hansen United States
Kieran Horgan United Kingdom
Mariana Chávez‐MacGregor United States
Michele A. Gadd United States
Jens‐Uwe Blohmer Germany
Mehra Golshan relative to Byeong‐Woo Park South Korea Byeong‐Woo Park's profile →
Citations per field
00.5×1.5×2.1×
Byeong‐Woo Park · 1×
Citations per year

Countries citing papers authored by Mehra Golshan

Since Specialization
Citations

This map shows the geographic impact of Mehra Golshan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehra Golshan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehra Golshan more than expected).

Fields of papers citing papers by Mehra Golshan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehra Golshan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehra Golshan. The network helps show where Mehra Golshan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mehra Golshan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mehra Golshan Line = papers co-authored together Mehra Golshan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 202118
3 20212
4 202117
5 201830
6 201861
7 201713
8 20171
9 201660
10 201559
11 201520
12 201515
13 20154
14
Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)breakdown →
2014650
15 2013152
16 20123
17 201026
18 2008125
19 200778
20 20032

About Mehra Golshan

Mehra Golshan is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 176 papers that have together received 6.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (118 papers), Breast Lesions and Carcinomas (70 papers), Breast Implant and Reconstruction (43 papers), Cancer Treatment and Pharmacology (27 papers), Global Cancer Incidence and Screening (19 papers), HER2/EGFR in Cancer Research (16 papers), BRCA gene mutations in cancer (13 papers) and Cancer and Skin Lesions (13 papers). The work is most often cited by research in Cancer Research (3.9k citations), Oncology (3.2k citations) and Pathology and Forensic Medicine (1.9k citations). Mehra Golshan has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Barbara L. Smith, Eric P. Winer, Stephanie M. Wong, Jennifer R. Bellon, William T. Barry, William M. Sikov, Yasuaki Sagara, Clifford A. Hudis, Fatih Aydoğan and George Somlo. Their work appears in journals such as Annals of Surgical Oncology, Journal of Clinical Oncology, The American Journal of Surgery, Breast Cancer Research and Treatment and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026